Please ensure Javascript is enabled for purposes of website accessibility

Why Teladoc Stock Soared 128% in the First Half of 2020

By Joe Tenebruso - Jul 5, 2020 at 3:35PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Virtual care is the future -- and, increasingly, the present -- of the healthcare industry.

What happened

Shares of Teladoc Health (TDOC 3.50%) rocketed 128% higher in the first six months of the year, according to data from S&P Global Market Intelligence. The telehealth leader is enjoying booming demand for its services.

So what 

With the coronavirus pandemic stretching hospitals around the world to their maximum capacity, health officials are desperately seeking new ways to deliver more care to more people. Telehealth services -- which help doctors and other healthcare professionals provide medical consultations via videoconferencing apps on patients' desktop computers and mobile devices -- are one of the best ways to do so.

A man speaking with a doctor via a videoconferencing app on his computer.

Teladoc is helping more people receive virtual care. Image source: Getty Images.

As the leading virtual care platform, Teladoc is growing at a torrid rate. Its first-quarter revenue climbed 41% year over year to $180.8 million, fueled by a 61% rise in U.S. paid memberships and a 92% surge in patient visits. 

Now what

Teladoc is already off to a strong start in the second half of the year. After strong gains in the first few days of July, the stock is now up 150% so far in 2020. Yet even after the stock's sharp rally, more gains may lie ahead for investors.

Teladoc is still early in its growth cycle. The rapidly expanding company pegs its potential patient base at as much as 1.1 billion people, which places its current customer count at only about 1% of its massive addressable market. 

Joe Tenebruso has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Teladoc Health. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Teladoc Health, Inc. Stock Quote
Teladoc Health, Inc.
$38.79 (3.50%) $1.31

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/09/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.